サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1427948

粒子線治療の世界市場レポート 2024

Particle Therapy Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
粒子線治療の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

粒子線治療の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には11.6%の年間複合成長率（CAGR）で19億5,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、ヘルスケア費の急増、がん以外にも広がるアプリケーションの出現、高齢者人口の増加、進行中のヘルスケアインフラ開発、AIとデータ分析の統合に関連している可能性があります。この期間中に予想される注目すべき動向には、粒子加速器技術の進歩、低分割技術の採用、陽子線と炭素イオンの併用療法の探求、患者の快適性の向上、生物学に基づく治療プロトコルの実施などが含まれます。

粒子線治療市場の予想される成長は、がんの罹患率の増加によって促進される態勢が整っています。がんは、体内の異常な細胞成長と増殖を特徴とする複雑で多様な疾患群であり、粒子線治療の需要を促進すると予想されます。この治療法では、正確で効果的な放射線を利用し、腫瘍に焦点を合わせて加速された正荷電粒子（陽子）を使用します。 2021年2月、米国に本拠を置く出版社ジョン・ワイリー・アンド・サンズ社の報告書は、2020年の世界の新規がん患者数は1,930万人、がんで死亡者数はほぼ1,000万人になるとの推計を示しました。 2020年には米国だけで160万人の新規感染者と602,347人のがん関連死亡者が発生しており、2022年 5月の疾病管理と予防の目標は、この健康上の課題に対処する上で粒子線治療が極めて重要な役割を果たしていることを強調しています。人口10万人当たり403人の新たながん症例と144人のがん関連死亡が記録されており、がんの有病率の上昇が粒子線治療市場の成長の重要な推進力となっています。

粒子線治療市場の成長は、高齢化人口の増加によってさらに促進されることが予想されます。社会における高齢者の割合の増加を特徴とするこの人口動態は、粒子線治療の需要を高めると予想されます。 粒子線治療は特に高齢者にとって重要であり、がん治療に対する正確で的を絞ったアプローチを提供します。これにより、周囲の健康な組織への損傷が最小限に抑えられ、長期的な副作用のリスクが軽減され、がん治療を受けている高齢患者の全体的な生活の質が向上します。世界保健機関は2022年 10月に、2030年までに世界の6人に1人が60歳以上になるとの予測を示しています。この期間中に、60歳以上の人口の割合は2020年の10億人から14億人に増加すると予想されています。さらに、世界の60歳以上の個人人口は2倍になり、2050年までに21億人に達すると予想されています。その結果、人口の高齢化は粒子線治療市場にとって重要な推進力となります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の粒子線治療市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 陽子線治療
  • 重粒子線治療
  • 世界の粒子線治療市場、システム別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • シングルルームシステム
  • マルチルームシステム
  • 世界の粒子線治療市場、がんタイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 小児がん
  • 前立腺がん
  • 肺がん
  • 乳がん
  • 脳および脊髄がん
  • その他のがんタイプ
  • 世界の粒子線治療市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院
  • 学術研究センター

第7章 地域および国の分析

  • 世界の粒子線治療市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の粒子線治療市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 粒子線治療市場の競合情勢
  • 粒子線治療市場の企業プロファイル
    • Hitachi Ltd.
    • Mitsubishi Electric Corporation
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • GE Healthcare

第31章 その他の大手および革新的な企業

  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems Inc.
  • Elekta AB
  • Shinva Medical Instrument Co. Ltd.
  • Toshiba Medical Systems Corporation
  • Brainlab AG
  • Accuray Incorporated
  • IBA Worldwide
  • Mevion Medical Systems Inc.
  • Avante Health Solutions
  • Provision Healthcare LLC
  • ViewRay
  • Panacea Biotec Ltd.
  • PTW Freiburg GmbH.
  • ProNova Solutions LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13792

Particle therapy is a specialized cancer treatment method that harnesses the energy of charged particles, such as protons or heavier ions, to administer radiation therapy to cancerous tumors. The fundamental principle of particle therapy involves directing energetic ionizing particles precisely at the tumor site for therapeutic purposes.

Two primary types of therapies fall under the umbrella of particle therapy, proton therapy and heavy ion therapy. Proton therapy is a specialized form of radiation therapy employed in cancer treatment. It encompasses both single-room systems and multi-room systems, providing versatility in its application. Proton therapy is utilized for the treatment of various cancers, including but not limited to pediatric cancer, prostate cancer, lung cancer, breast cancer, and cancers affecting the brain and spinal cord. The primary end users of particle therapy are hospitals, academic institutions, and research centers. Particle therapy offers a targeted and precise approach to cancer treatment, minimizing damage to surrounding healthy tissues and enhancing the therapeutic effectiveness of radiation.

The particle therapy market research report is one of a series of new reports from The Business Research Company that provides particle therapy market statistics, including particle therapy industry global market size, regional shares, competitors with a particle therapy market share, detailed particle therapy market segments, market trends and opportunities, and any further data you may need to thrive in the particle therapy industry. This particle therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The particle therapy market size has grown rapidly in recent years. It will grow from $1.11 billion in 2023 to $1.26 billion in 2024 at a compound annual growth rate (CAGR) of 12.9%. The growth witnessed in the past period can be attributed to progress in clinical research and studies, an increase in cancer incidence rates, government support and financial backing, industry collaboration, and improvements in treatment planning.

The particle therapy market size is expected to see rapid growth in the next few years. It will grow to $1.95 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The anticipated growth in the forecast period can be linked to a surge in healthcare expenditure, the emergence of applications extending beyond cancer, a rise in the geriatric population, ongoing healthcare infrastructure development, and the integration of AI and data analytics. Noteworthy trends expected during this period encompass advancements in particle accelerator technology, the adoption of hypofractionation techniques, the exploration of proton and carbon ion combination therapy, enhancements in patient comfort, and the implementation of biology-driven treatment protocols.

The anticipated growth of the particle therapy market is poised to be propelled by the increasing prevalence of cancer. Cancer, a complex and diverse group of diseases characterized by abnormal cell growth and proliferation in the body, is expected to drive demand for particle therapy. This form of treatment utilizes precise and effective radiation, employing accelerated positively charged particles (protons) focused on the tumor. In February 2021, reports from John Wiley & Sons Inc., a US-based publishing company, indicated a global estimate of 19.3 million new cancer cases and almost 10.0 million cancer deaths in 2020. The growth of cancer cases, as highlighted by the Centers for Disease Control and Prevention in May 2022, with 1.60 million new cases and 602,347 cancer-related deaths in the US alone in 2020, underscores the pivotal role of particle therapy in addressing this health challenge. With 403 new cancer cases and 144 cancer-related deaths recorded per 100,000 people, the rising prevalence of cancer is a key driver for the growth of the particle therapy market.

The growth in the particle therapy market is expected to be further propelled by the increasing aging population. This demographic trend, characterized by a growing proportion of elderly individuals in society, is expected to boost demand for particle therapy. Particle therapy is particularly significant for the geriatric population, offering a precise and targeted approach to cancer treatment. This minimizes damage to surrounding healthy tissues, reduces the risk of long-term side effects, and enhances the overall quality of life for elderly patients undergoing cancer therapy. According to the World Health Organization in October 2022, projections indicate that by 2030, 1 out of every 6 individuals globally would be 60 years old or older. During this period, the proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion. Furthermore, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion by 2050. Consequently, the aging population is a significant driver for the particle therapy market.

An emerging trend gaining traction in the particle therapy market is the adoption of advanced particle therapy platforms. Major players in the market are actively engaged in the development of innovative platforms to maintain and strengthen their market positions. Notably, in October 2021, Ion Beam Applications S.A. (IBA), a medical technology company based in Belgium, introduced the world's first online proton therapy platform. This web-based platform offers a diverse range of resources, including educational materials on proton therapy, discussion forums, and information on clinical trials. Additionally, the platform features a virtual reality (V.R.) tour of a proton therapy center, allowing users to experience the process of receiving proton therapy. This comprehensive platform serves as a valuable tool for clinicians, researchers, and patients dedicated to improving the lives of individuals affected by cancer.

Key companies in the particle therapy market are intensifying their efforts to develop innovative therapies, with a particular focus on proton therapy solutions, to gain a competitive advantage. Proton therapy technology, a sophisticated form of cancer treatment utilizing protons and positively charged particles, delivers precise and targeted radiation to cancer cells. For instance, in April 2023, P-Cure, an Israel-based high-med-tech company, obtained clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing sales in the USA. This affordable proton therapy technology is designed for targeted cancer treatment with significantly reduced treatment-related side effects. P-Cure's innovative upright solution, the world's first FDA-approved methodology for patient positioning, enables seated treatment, enhancing both patient comfort and clinical outcomes.

In May 2022, Brainlab AG, a Germany-based medical technology company, acquired a majority stake in medPhoton GmbH for an undisclosed amount. This strategic acquisition aims to expand Brainlab's intraoperative imaging portfolio, drive business growth, bolster product development, and accelerate innovation in the critical field of medical technology. medPhoton GmbH, an Austria-based medical equipment manufacturing company, specializes in providing particle therapy devices and services.

Major companies operating in the particle therapy market report are Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy PLC, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.

North America was the largest region in the particle therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the particle therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The particle therapy market includes of revenues earned by entities by providing particle therapy services such as treatment planning, particle beam delivery, imaging and simulation, treatment sessions, patient monitoring, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Particle Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on particle therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for particle therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The particle therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Proton Therapy; Heavy Ion Therapy
  • 2) By System: Single-Room Systems; Multi-Room Systems
  • 3) By Cancer Type: Pediatric Cancer; Prostate Cancer; Lung Cancer; Breast Cancer; Brain And Spinal Cord Cancer; Other Cancer Types
  • 4) By End-User: Hospital; Academic And Research Centers
  • Companies Mentioned: Hitachi Ltd.; Mitsubishi Electric Corporation; Siemens Healthineers AG; Koninklijke Philips N.V; GE Healthcare
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Particle Therapy Market Characteristics

3. Particle Therapy Market Trends And Strategies

4. Particle Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Particle Therapy Market Size and Growth

  • 5.1. Global Particle Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Particle Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Particle Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Particle Therapy Market Segmentation

  • 6.1. Global Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Proton Therapy
  • Heavy Ion Therapy
  • 6.2. Global Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Single-Room Systems
  • Multi-Room Systems
  • 6.3. Global Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pediatric Cancer
  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Brain And Spinal Cord Cancer
  • Other Cancer Types
  • 6.4. Global Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Academic And Research Centers

7. Particle Therapy Market Regional And Country Analysis

  • 7.1. Global Particle Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Particle Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Particle Therapy Market

  • 8.1. Asia-Pacific Particle Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Particle Therapy Market

  • 9.1. China Particle Therapy Market Overview
  • 9.2. China Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Particle Therapy Market

  • 10.1. India Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Particle Therapy Market

  • 11.1. Japan Particle Therapy Market Overview
  • 11.2. Japan Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Particle Therapy Market

  • 12.1. Australia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Particle Therapy Market

  • 13.1. Indonesia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Particle Therapy Market

  • 14.1. South Korea Particle Therapy Market Overview
  • 14.2. South Korea Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Particle Therapy Market

  • 15.1. Western Europe Particle Therapy Market Overview
  • 15.2. Western Europe Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Particle Therapy Market

  • 16.1. UK Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Particle Therapy Market

  • 17.1. Germany Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Particle Therapy Market

  • 18.1. France Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Particle Therapy Market

  • 19.1. Italy Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Particle Therapy Market

  • 20.1. Spain Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Particle Therapy Market

  • 21.1. Eastern Europe Particle Therapy Market Overview
  • 21.2. Eastern Europe Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Particle Therapy Market

  • 22.1. Russia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Particle Therapy Market

  • 23.1. North America Particle Therapy Market Overview
  • 23.2. North America Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Particle Therapy Market

  • 24.1. USA Particle Therapy Market Overview
  • 24.2. USA Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Particle Therapy Market

  • 25.1. Canada Particle Therapy Market Overview
  • 25.2. Canada Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Particle Therapy Market

  • 26.1. South America Particle Therapy Market Overview
  • 26.2. South America Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Particle Therapy Market

  • 27.1. Brazil Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Particle Therapy Market

  • 28.1. Middle East Particle Therapy Market Overview
  • 28.2. Middle East Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Particle Therapy Market

  • 29.1. Africa Particle Therapy Market Overview
  • 29.2. Africa Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Particle Therapy Market, Segmentation By System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Particle Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Particle Therapy Market Competitive Landscape
  • 30.2. Particle Therapy Market Company Profiles
    • 30.2.1. Hitachi Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Mitsubishi Electric Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Koninklijke Philips N.V
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GE Healthcare
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Particle Therapy Market Other Major And Innovative Companies

  • 31.1. Sumitomo Heavy Industries Ltd.
  • 31.2. Varian Medical Systems Inc.
  • 31.3. Elekta AB
  • 31.4. Shinva Medical Instrument Co. Ltd.
  • 31.5. Toshiba Medical Systems Corporation
  • 31.6. Brainlab AG
  • 31.7. Accuray Incorporated
  • 31.8. IBA Worldwide
  • 31.9. Mevion Medical Systems Inc.
  • 31.10. Avante Health Solutions
  • 31.11. Provision Healthcare LLC
  • 31.12. ViewRay
  • 31.13. Panacea Biotec Ltd.
  • 31.14. PTW Freiburg GmbH.
  • 31.15. ProNova Solutions LLC

32. Global Particle Therapy Market Competitive Benchmarking

33. Global Particle Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Particle Therapy Market

35. Particle Therapy Market Future Outlook and Potential Analysis

  • 35.1 Particle Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Particle Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Particle Therapy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer